Tenax Therapeutics (TENX) Stock Highlights

5.61 | +0.9%

2024-12-21 07:36:52

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction.

Statistics

Range Today

5.39 5.78

Volume Today 21.1K

Range 1 Year

2.77 27.36

Volume 1 Year 59.9M

Range 3 Year

2.77 2334.4

Volume 3 Year 70M

Range 10 Year

2.77 127360

Volume 10 Year 70.44M

Highlights

Market Capitalization 16.4M (micro)

Floating Shares 2.64M

Current Price 5.61

Price To Earnings -0.21

Price To Book 1.05

Earnings Per Share -22.59

Payout Ratio 0%

Performance

Latest +0.9%

1 Month +15.43%

3 Months +54.55%

6 Months +81.55%

1 Year -76.63%

3 Years -99.69%

5 Years -99.7%

10 Years -100%

Benchmarks

Market Capitalization

351 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

277 / 368

Free Cashflow

66 / 352

Performance 5 years

363 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.